Chimeric and humanized antibodies to alpha5beta1 integrin that modulate angiogenesis

Details for Australian Patent Application No. 2003298783 (hide)

Owner Facet Biotech Corporation

Inventors Jeffry, Ursula; Ramakrishnan, Vanitha; Johnson, Dale E.; Powers, David

Agent Shelston IP

Pub. Number AU-B-2003298783

PCT Number PCT/US2003/0381

PCT Pub. Number WO2004/056308

Priority 60/429,743 26.11.02 US

Filing date 26 November 2003

Wipo publication date 14 July 2004

Acceptance publication date 4 November 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/42 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

Event Publications

6 May 2004 Complete Application Filed

  Priority application(s): 60/429,743 26.11.02 US

19 August 2004 Application Open to Public Inspection

  Published as AU-B-2003298783

23 April 2009 Assignment before Grant

  PDL BioPharma, Inc. The application has been assigned to Facet Biotech Corporation 2004

4 November 2010 Application Accepted

  Published as AU-B-2003298783

20 January 2011 Alteration of Name

  The name of the applicant has been altered to Abbott Biotherapeutics Corp. 2004

3 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003298784-LABELING APPARATUS AND METHOD OF MAKING SAME

2003298782-ADHESIVE ARTICLES, METHOD FOR MAKING AND USES FOR SAME